Associations between levels of serum perfluorinated chemicals and adiponectin in a young hypertension cohort in Taiwan

Environmental Science and Technology

Volumn 45, Issue 24, 2011, Pages 10691-10698

  Lin, Chien Yu ^a,b   Wen, Li Li ^a   Lin, Lian Yu ^c   Wen, Ting Wen ^d   Lien, Guang Wen ^d   Chen, Chia Yang ^d   Hsu, Sandy H J ^c   Chien, Kuo Liong ^d   Sung, Fung Chang ^e   Chen, Pau Chung ^d   Su, Ta Chen ^c  

^a EN CHU KONG HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; FULL MODEL; GLUCOSE HOMEOSTASIS; LIPID PROFILE; MEDIAN CONCENTRATION; METABOLIC SYNDROMES; MULTIPLE LINEAR REGRESSION ANALYSIS; PERFLUORINATED CHEMICALS; PERFLUORONONANOIC ACIDS; PERFLUOROOCTANOIC ACID; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; SERUM ADIPONECTIN; SERUM LEVELS;

ANIMALS; CONCENTRATION (PROCESS); CYTOLOGY; GLUCOSE; LINEAR REGRESSION;

BODY FLUIDS;

ADIPONECTIN; PERFLUORO COMPOUND; PERFLUORONONANOIC ACID; PERFLUOROOCTANE SULFATE; PERFLUOROOCTANOIC ACID; PERFLUOROUNDECANOIC ACID; UNCLASSIFIED DRUG;

BIOCHEMISTRY; COHORT ANALYSIS; CONCENTRATION (COMPOSITION); DRUG; HOMEOSTASIS; HYPERTENSION; MULTIPLE REGRESSION; PEPTIDE; PUBLIC HEALTH; RODENT; SERUM; SEX-RELATED DIFFERENCE; YOUNG POPULATION;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; CHILD; CONTROLLED STUDY; FEMALE; GLUCOSE HOMEOSTASIS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIPLE LINEAR REGRESSION ANALYSIS; SCHOOL CHILD; SEX DIFFERENCE; TAIWAN;

ADIPONECTIN; ADOLESCENT; ADULT; CHILD; COHORT STUDIES; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; FLUOROCARBONS; HUMANS; HYPERTENSION; MALE; TAIWAN; YOUNG ADULT;

TAIWAN;

EID: 83455170712     PISSN: 0013936X     EISSN: 15205851     Source Type: Journal    
DOI: 10.1021/es201964x     Document Type: Article

References (39)

1. Kudo, N.; Bandi, N.; Suzuki, E.; Katakura, M.; Kawashima, Y. Induction by perfluorinated fatty acids with different carbon chain length of peroxisomal b-oxidation in the liver of rats Chem. Biol. Interact. 2000, 124, 119-132 (Pubitemid 30009706)
2. Guruge, K. S.; Yeung, L. W. Y.; Yamanaka, N.; Miyazaki, S.; Lam, P. K. S.; Giesy, J. P.; Jones, P. D.; Yamashita, N. Gene expression profiles in rat liver treated with perfluorooctaonic acid (PFOA) Toxicol. Sci. 2006, 89, 93-107 (Pubitemid 43013759)
3. Hines, E. P.; White, S. S.; Stanko, J. P.; Gibbs-Flournoy, E. A.; Lau, C.; Fenton, S. E. Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: Low doses induce elevated serum leptin and insulin, and overweight in mid-life Mol. Cell. Endocrinol. 2009, 304, 97-105
4. Loveless, S. E.; Finlay, C.; Everds, N. E.; Frame, S. R.; Gillies, P. J.; OConnor, J. C.; Powley, C. R.; Kennedy, G. L. Comparative responses of rats and mice exposed to linear/branched, linear, or branched ammonium perfluorooctanoate (APFO) Toxicology 2006, 220, 203-217 (Pubitemid 43276409)
5. Olsen, G. W.; Burris, J. M.; Burlew, M. M.; Mandel, J. H. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations J. Occup. Environ. Med. 2003, 45, 260-270 (Pubitemid 36343227)
6. Olsen, G. W.; Burlew, M. M.; Marshall, J. C.; Burris, J. M.; Mandel, J. H. Analysis of episodes of care in a perfluorooctanesulfonyl fluoride production facility J. Occup. Environ. Med. 2004, 46, 837-846 (Pubitemid 39093775)
7. Olsen, G. W.; Zobel, L. R. Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers Int. Arch. Occup. Environ. Health. 2007, 81, 231-246 (Pubitemid 47617455)
8. Sakr, C. J.; Kreckmann, K. H.; Green, J. W.; Gillies, P. J.; Reynolds, J. L.; Leonard, R. C. Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers J. Occup. Environ. Med. 2007, 49, 1086-1096 (Pubitemid 350287341)
9. Sakr, C. J.; Leonard, R. C.; Kreckmann, K. H.; Slade, M. D.; Cullen, M. R. Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate Occup. Environ. Med. 2007, 49, 872-879 (Pubitemid 47254709)
10. Steenland, K.; Tinker, S.; Frisbee, S.; Ducatman, A.; Vaccarino, V. Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant Am. J. Epidemiol. 2009, 170, 1268-1278
11. Frisbee, S. J.; Shankar, A.; Knox, S. S.; Steenland, K.; Savitz, D. A.; Fletcher, T.; Ducatman, A. M. Perfluorooctanoic cid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the c8 health project Arch. Pediatr. Adolesc. Med. 2010, 164, 860-869
12. Steenland, K.; Tinker, S.; Shankar, A.; Ducatman, A. Association of perfluorooctanoic acid (PFOA) and perfluorooctanesulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA Environ. Health Prospect. 2010, 118, 229-233
13. Nelson, J.; Hatch, E.; Webster, T. Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population Environ. Health Perspect. 2010, 118, 197-202
14. MacNeil, J.; Steenland, N. K.; Shankar, A.; Ducatman, A. A cross-sectional analysis of type II diabetes in a community with exposure to perfluorooctanoic acid (PFOA) Environ. Res. 2009, 109, 997-1003
15. Lin, C. Y.; Chen, P. C.; Lin, Y. C.; Lin, L. Y. Association among serum perfluoroalkyl chemicals, glucose homeostasis and metabolic syndrome in adolescents and adults Diabetes Care 2009, 32, 702-707
16. Matsuzawa, Y.; Funahashi, T.; Kihara, S.; Shimomura, I. Adiponectin and metabolic syndrome Arterioscler., Thromb., Vasc. Biol. 2004, 24, 29-33 (Pubitemid 38082408)
17. Rasouli, N.; Yao-Borengasser, A.; Miles, L. M.; Elbein, S. C.; Kern, P. A. Increased plasma adiponectin in response to pioglitazone does not result from increased gene expression Am. J. Physiol.: Endocrinol. Metab. 2006, 290, E42-E46
18. Wei, J. N.; Sung, F. C.; Lin, C. C.; Lin, R. S.; Chiang, C. C.; Chuang, L. M. National surveillance for type 2 diabetes mellitus in Taiwanese children JAMA, J. Am. Med. Assoc. 2003, 290, 1345-1350
19. Tsai, C. W.; Kuo, C. C.; Wu, C. F.; Chien, K. L.; Wu, V. C.; Chen, M. F.; Sung, F. C.; Su., T. C. Associations of renal vascular resistance with albuminuria in adolescents and young adults. Nephrol., Dial., Transplant. 2011, Mar 28. [Epub ahead of print].
20. Chu, C. S.; Lee, K. T.; Lee, M. Y.; Su, H. M.; Voon, W. C.; Sheu, S. H.; Lai, W. T. Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus Am. J. Cardiol. 2006, 97, 646-650
21. Drzewoski, J.; Zurawska-Klis, M. Effect of gliclazide modified release on adiponectin, interleukin-6, and tumor necrosis factor-alpha plasma levels in individuals with type 2 diabetes mellitus Curr. Med. Res. Opin. 2006, 22, 1921-1926 (Pubitemid 44663396)
22. Weitzman, M.; Cook, S.; Auinger, P.; Florin, T. A.; Daniels, S.; Nguyen, M.; Winickoff, J. P. Tobacco smoke exposure is associated with the metabolic syndrome in adolescents Circulation 2005, 112, 862-869 (Pubitemid 41170073)
23. Wallace, T. M.; Levy, J. C.; Matthews, D. R. Use and abuse of HOMA modeling Diabetes Care 2004, 27, 1487-1495 (Pubitemid 38680001)
24. Goodfriend, T. L.; Sowers, J. R.; Messerli, F. H.; Cutler, J. A.; Sheps, S. G.; Vidt, D. G. Hypertension Primer: The Essential of High Blood Pressure; American Heart Association: Dallas, 2003.
25. Lien, G. W.; Wen, T. W.; Hsieh, W. S.; Wu, K. Y.; Chen, C. Y.; Chen, P. C. Analysis of perfluorinated chemicals in umbilical cord blood by ultra-high performance liquid chromatography/tandem mass spectrometry J. Chromatogr., B: Analyt. Technol. Biomed. Life. Sci. 2011, 879, 641-646
26. Grundy, S. M.; Brewer, H. B.; Cleeman, J. I.; Smith, S. C.; Lenfant, D. Definition of metabolic syndrome: report of the National, Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Circulation 2004, 109, 433-438 (Pubitemid 38133916)
27. Jolliffe, C. J.; Janssen, I. Development of age-specific adolescent metabolic syndrome criteria that are linked to the adult treatment panel III and international diabetes federation criteria J. Am. Coll. Cardiol. 2007, 49, 891-898 (Pubitemid 46275357)
28. Cnop, M.; Havel, P. J.; Utzschneider, K. M.; Carr, D. B.; Sinha, M. K.; Boyko, E. J.; Retzlaff, B. M.; Knopp, R. H.; Brunzell, J. D.; Kahn, S. E. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex Diabetologia 2003, 46, 459-469 (Pubitemid 36577787)
29. Abbasi, F.; Farin, H. M.; Lamendola, C.; McLaughlin, T.; Schwartz, E. A.; Reaven, G. M.; Reaven, P. D. The relationship between plasma adiponectin concentration and insulin resistance is altered in smokers J. Clin. Endocrinol. Metab. 2006, 91, 5002-5007 (Pubitemid 44917341)
30. Guebre-Egziabher, F.; Bernhard, J.; Funahashi, T.; Hadj-Aissa, A.; Fouque, D. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function Nephrol., Dial., Transplant 2005, 20, 129-134 (Pubitemid 40207617)
31. Calafat, A. M.; Wong, L. Y.; Kuklenyik, Z.; Reidy, J. A.; Needham, L. L. Polyfluoroalkyl chemicals in the U.S. population: Data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000 Environ. Health Perspect. 2007, 115 (11) 1596-1602
32. Lin, A. Y.; Panchangam, S. C.; Lo, C. C. The impact of semiconductor, electronics and optoelectronic industries on downstream perfluorinated chemical contamination in Taiwanese rivers Environ. Pollut. 2009, 157 (4) 1365-1372
33. Fang, X.; Zhang, L.; Feng, Y.; Zhao, Y.; Dai, J. Immunotoxic effects of perfluorononanoic acid on BALB/c mice Toxicol. Sci. 2008, 105, 312-321
34. Paumelle, R.; Staels, B. Cross-talk between statins and PPARalpha in cardiovascular diseases: clinical evidence and basic mechanisms Trends. Cardiovasc. Med. 2008, 18, 73-78 (Pubitemid 351626602)
35. Klaunig, J. E.; Babich, M. A.; Baetcke, K. P.; Cook, J. C.; Corton, J. C.; David, R. M.; DeLuca, J. G.; Lai, D. Y.; McKee, R. H.; Peters, J. M.; Roberts, R. A.; Fenner-Crisp, P. A. PPAR agonist-induced rodent tumors: modes of action and human relevance Crit. Rev. Toxicol. 2003, 33, 655-780 (Pubitemid 38037444)
36. Takacs, M. L.; Abbott, B. D. Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate Toxicol. Sci. 2007, 95, 108-117 (Pubitemid 44942782)
37. Abbott, B. D. Review of the expression of peroxisome proliferator- activated receptors alpha (PPAR alpha), beta (PPAR beta), and gamma (PPAR gamma) in rodent and human development Reprod. Toxicol. 2009, 27, 246-257
38. Li, S.; Shin, H. J.; Ding, E. L.; Van Dam, R. M. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis JAMA, J. Am. Med. Assoc. 2009, 302, 179-188
39. Böttner, A.; Kratzsch, J.; Müller, G.; Kapellen, T. M.; Blüher, S.; Keller, E.; Blüher, M.; Kiess, W. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels J. Clin. Endocrinol. Metab. 2004, 89, 4053-4061 (Pubitemid 39071513)